PBS reviews red tape for arthritis drugs

Drugs for arthritic conditions will be the first to benefit from a review of PBS prescribing restrictions and red tape. 

In its newly-launched Post-market Review of Authority Required PBS Listings , the PBS said drugs for rheumatoid arthritis and other arthritis medicines had been identified being among those with the highest regulatory burden, along with drugs for cancer. 

Therefore, these drugs will be included in the first